ALLETE, Inc. (ALE) Misses Q3 EPS by 6c; Reaffirms

ALLETE, Inc. (NYSE: ALE) reported Q3 EPS of $0.88, $0.06 worse than the analyst estimate of $0.94. Revenue for the quarter came in at $362.5 million versus the consensus estimate of $358 million.

“We remain on track to meet our full-year earnings targets,” said ALLETE Chairman, President and CEO Al Hodnik. “We expect 2017 earnings to be within a range of $3.15 to $3.40 per share, excluding the impact of the MPUC's modification of its November 2016 order on the allocation of North Dakota investment tax credits. We have made many accomplishments during the year and are pleased that our efforts are delivering value to ALLETE’s shareholders. We believe we are well positioned to deliver additional long-term value to our shareholders with our unique mix of businesses.”

For earnings history and earnings-related data on ALLETE, Inc. (ALE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c